JPRN-UMIN000042853尚未招募未知
A randomized, open-label, parallel-group study of the efficacy of oral Ninjin'yoeito in improving fatigability and nutritional status in the perioperative period of primary lung cancer - Efficacy of oral Ninjin'yoeito for improvement of fatigability and nutritional status in the perioperative period of primary lung cancer
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 65years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. The patient does not give consent to participate in the study. 2.The patient has a history of allergy to Ninjin'yoeito or its components. 3. The patient has severe anorexia, nausea, or vomiting, which is a cautious administration of the study drug. 4. The patient with severe hepatic or renal dysfunction.
研究者
相似试验
招募中
不适用
Efficacy of oral Ninjin'yoeito for improvement of fatigability and nutritional status in the perioperative period of primary lung cancerPrimary lung cancerprimary lung cance, non-small cell lung cancer, small cell lung cancerD002289, D055752JPRN-jRCT1031210136Ishibashi Hironori332
进行中（未招募）
不适用
A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One TNF-InhibitorEUCTR2010-023587-40-SEF. Hoffmann-La Roche Ltd.96
进行中（未招募）
不适用
A randomized, open-label, parallel-group study to investigate blood concentrations, safety and tolerability of 2 ointment formulations of ASM981 in adult patients with atopic dermatitis treated topically for 2 weeks - A2308Atopic dermatitis (atopic eczema)EUCTR2004-003798-94-ATovartis Pharma Services AG20
尚未招募
不适用
A randomized, open-label, parallel-group study to evaluate the efficacy of dry chemical mopping in adults with mild to moderate atopic dermatitis.Atopic dermatitis of mild to moderate severityJPRN-UMIN000045727Mie University, Graduate School of Medicine42
尚未招募
3 期
The Study to evaluate the effectiveness of Abrocitinib Tablets in People With Atopic Dermatitis in IndiaCTRI/2022/06/043406Pfizer Inc